BEGESAND
Live / Registered — Cancelled — Section 71 (as of 26 Jul 2024)
What this means for you
Registered since 09 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79201532
- Registration number
- 5372122
- Mark type
- Stylized text
- Filed
- 08 Sept 2016
- Published for opposition
- 24 Oct 2017
- Registered
- 09 Jan 2018
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; medical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; and veterinary preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, and substances in the nature of beverages for medical or veterinary use; monoclonal antibodies and antibody mixtures for medical use, namely, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; monoclonal antibodies for immunomodulatory treatments, in particular for the treatment of diseases mediated by the differentiation cluster 26 molecule CD26; pharmaceutical preparations comprising as active ingredient monoclonal antibodies having immunomodulatory effects, in particular for the treatment of diseases mediated by the 26 differentiation cluster molecule CD26; dietetic foods, namely, yogurt and rice-derived products, namely, rice flour adapted for medical use, dietetic beverages adapted for medical use, food supplements, enzyme food supplements, protein food supplements, protein supplements for animals, by-products of the processing of cereals for dietetic or medical use, biological preparations for medical use, biological preparations for veterinary use, pills for medicines, namely, immunosuppressant pills, chemical preparations for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, chemical preparations for veterinary use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, biological tissue cultures for medical use, biological tissue cultures for veterinary use, enzyme preparations for medical use, enzyme preparations for veterinary use, enzymes for medical use, enzymes for veterinary use, medicines for veterinary use for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for veterinary use, namely, monoclonal antibodies for immunomodulatory treatments, vaccines, veterinary products in the nature of anti-infective products for veterinary use; living tissue grafts, surgical implants composed of living tissue, radiological contrast substances for medical use, diagnostic preparations for medical use, biomarker reagents for diagnosis for medical use, adjuvants for medical use, chemical preparations for pharmaceutical use, drugs for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations, namely, elixirs for treating viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, plant extracts for pharmaceutical use, medicinal infusions for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, lotions for pharmaceutical use, medicines or human medicine for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for human medicine in the nature of solution for injection for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, syrups for pharmaceutical use for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders
- Class 010 — Medical apparatus: Surgical, medical, dental and veterinary apparatus and instruments, namely, infusion bag, vial, syringe; needles for medical use, medical apparatus and instruments, containers for applying medicines, namely, infusion bag, vial, syringe, hypodermic syringes, syringes for medical use, pumps for medical use, namely, infusion pump
Owner
- ADIENNE SA, XOX
- ADIENNE SA, XOX
- ADIENNE SA, XOX
Prosecution history
- 11 Jul 2025 — TOTAL INVALIDATION PROCESSED BY THE IB
- 24 Jun 2025 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 24 Jun 2025 — INVALIDATION PROCESSED
- 26 Mar 2025 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Jul 2024 — CANCELLED SECTION 71
- 09 Jan 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 31 Dec 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Jun 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Apr 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Apr 2018 — FINAL DISPOSITION PROCESSED
- 09 Apr 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Oct 2017 — PUBLISHED FOR OPPOSITION
- 21 Oct 2017 — NOTIFICATION PROCESSED BY IB